SpeeDx
Empowering clinicians to make informed treatment decisions.SpeeDx
Founded in 2009, SpeeDx is an Australian-based private company with offices in London and the US, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease.
Images
Blog Posts
8th April, 2024
SpeeDx launch next generation PCR multiplexing technology
Inaugural RespiV PlexPlus®* product showcases advantages SpeeDx unveils a new innovative spin on qPC...
7th December, 2023
Exciting expansion as SpeeDx adds concise gastroenteritis panels to their Research offerings
EntericPlex* products Sharpen Your Focus SpeeDx have released a suite of gastroenteritis panels, the...
1st September, 2023
SpeeDx releases Compact Respiratory Multiplex in advance of UK winter
Upfront diagnosis. Combat seasonal testing surges with ease PlexPCR® Flu/RSV/SARS-CoV-2 detects Infl...
11th July, 2023
SpeeDx announce expansion of their research offering.
SpeeDx Pty. Ltd., have released a new Research Use Only (RUO) product providing an exciting expansio...
19th June, 2023
Adjunct Professor Alison Todd, FTSE PhD awarded Member (AM) in the general division of the Order of Australia
Adjunct Professor Alison Todd, AM FTSE PhD, a distinguished figure in the field of medical research ...
26th May, 2023
Bringing diagnostics up to speed to tackle antimicrobial resistance
Alison Todd and Elisa Mokany are developing diagnostic tests that can detect antimicrobial resistanc...
17th May, 2023
SpeeDx adds Biosapientia to Distribution Network
Partnership with Biosapientia expands SpeeDx product availability in France SYDNEY, AUSTRALIA – (May...
13th April, 2023
Andrew Forrest-backed firm SpeeDx moves to avoid PNG becoming a hotspot for virus mutations
EXCLUSIVE By JARED LYNCH REPORTER @jaredm_lynch APRIL 10, 2023 A diagnostics company backed by minin...
14th March, 2023
PCR-test blitz urged to counter Melbourne’s syphilis surge
The Age Melissa Cunningham February 25, 2023 — 7.30pm Sexual health physicians are pushing for PCR t...
28th February, 2023
SpeeDx raises $26 million to accelerate new technology development and commercial expansion
Funds will accelerate technology development to increase actionable patient results per test SYDNEY ...